October #106 : Bangkok Big Top - by David Gelman, MD

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents

Crime no. 69

Who’s Afraid of HU?

Six Nights in Bangkok

Their Patients, Their People

Thar She Blows!

HU Handbook

Top Black MDs

Heartbreak Hotel

Quilt Trip


No PEP Rally


Show & Tell



Pos & Neg

Meth-od Actor

West Denial Virus

Bangkok Big Top


Private Parts

Forbidden Grapefruit

Quick Study: Prostate

Alzheimer’s Drug Does HIV

Body Eclectic: Lungs

Get Flu-ent

If You Knew Sushi


Trip or Treat

Scared Straight

Hitched & Bewitched


Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

email print

October 2004

Bangkok Big Top

by David Gelman, MD

Elephants prancing on the logo of July’s International AIDS conference in Thailand (see “Six Nights in Bangkok”) trumpeted no big scientific breakthroughs. But for HIVers pondering pills and tweaking regimens, David Gelman, MD, tackles some treatment tidbits:


Getting a different strain of HIV on top of your first seems less common than we’d thought—if you’ve had HIV a while. Twenty-eight San Francisco HIVer couples didn’t pass diverse viral strains to one another despite repeated condomless anal or vaginal sex. In 3,000-plus sexual escapades by 30 other HIVers, the only superinfection arose in a newly positive person. Looks like superinfection may strike only if you’re re-exposed soon after the first infection.


It’s a HAART-era heresy: A small (30-HIVer) study showed folks just starting HIV meds may be able to get away with taking Kaletra (lopinavir plus ritonavir) alone. The trial was plagued by dropouts, due to problems mostly unrelated to HIV. But all who continued through 48 weeks got to viral loads under 400—without any resistance showing up.


Strategic Treatment Interruption tips: A small study showed promise for five days on meds, two off—best with non-nuke combos. n Two trials said you can stop as long as you restart when CD4s drop below 350. n In another small trial, HIVers resistant to 3TC (Epivir) who took that drug alone during breaks did better than those off all meds.

26%of Fuzeon (T-20) takers still had their virus controlled after 96 weeks.

Plus: bone-cement injections fill sunken faces for only $500...haart suppressed viral load but didn’t raise cd4 counts of hep C coinfectees...entry inhibitors keep showing promise...in once-daily dose, kaletra levels may be too low...antifungal fluconazole (like diflucan) may lift viramune (nevirapine) levels too high...

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.